This inventor holds 6 USPTO granted patents and 2 EPO patents. Top assignees: Dynport Vaccine Company LLC, Health Protection Agency, Immunobiology Limited. Active years: 2008-2020.
Company Filing History:
4 out of 4 
4 out of 38 
2 out of 4 Years Active: 2008-2020
Title: Ian McEntee: Innovator in Vaccine Development
Introduction
Ian McEntee is a notable inventor based in Salisbury, GB. He has made significant contributions to the field of vaccine development, holding a total of 6 patents. His work focuses on innovative methods for producing protein complexes that are crucial for vaccine compositions.
Latest Patents
One of Ian McEntee's latest patents is a method for the production of heat shock protein complexes for use in vaccine compositions. This invention relates to techniques for increasing the level and immunogenicity of these complexes by subjecting cells to specific stress-inducing stimuli. The patent further extends to the application of these heat shock protein complexes in preparing vaccine compositions aimed at preventing and treating infectious diseases and cancerous conditions.
Career Highlights
Throughout his career, Ian McEntee has worked with prominent organizations such as Dynport Vaccine Company and the Health Protection Agency. His experience in these companies has allowed him to develop and refine his innovative approaches to vaccine technology.
Collaborations
Ian has collaborated with notable colleagues, including Philip Vincent and Nigel Allison, contributing to advancements in the field of vaccine research and development.
Conclusion
Ian McEntee's work in the production of protein complexes for vaccine compositions showcases his dedication to improving public health through innovative solutions. His contributions are vital in the ongoing fight against infectious diseases and cancer.